Finished
Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions
NCT05674123 · Mayo Clinic · Updated 12 Jan 2023
- What is being tested
- Colonoscopy; Endoscopic Ultrasound; Medical Chart Review; Medical Device Usage and Evaluation; Resection
- For
- Colorectal Neoplasm
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 22 years and older. About 2 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started 15 Jan 2020, ends 10 June 2022. Registered 6 Jan 2023.
- Results
- None posted yet.
In the researchers' words
This clinical trial assesses the safety and effectiveness of a new device called the Flex Robotic System in the surgical removal (resection) of colorectal lesions. When an area of abnormal tissue called a lesion is found in the colon or rectum, it is often not known if the lesion is cancerous or non-cancerous. Recommendation to remove the lesion may be made. Current methods of resection can be challenging and time-consuming. The Flex Robotic System is a new device that provides a stable working environment, better ability to grasp and cut lesions, and better tissue handling when performing a resection. The Flex Robotic system may be more effective at removing colorectal lesions than standard resection techniques.
Sites
- Mayo Clinic in RochesterRochester, Minnesota, United States